Benjamin Hickey, EVP, Chief Commercial Officer at Mirati Therapeutics, Inc. (MRTX), sold 1,254 shares at $120.48 ($151K) on 2022-01-18, disclosed to the SEC on 2022-01-18.
Open-market sale of $151k MRTX by EVP, Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $120.48 | 627 | $76K | 50.0% |
| 2 | $120.48 | 627 | $76K | 50.0% |
| Total | $120.48 avg | 1,254 | $151K | 100% |
| Filing → |
| MRTX | SELL | 2024-01-09 | $246K | — | Filing → |
| MRTX | SELL | 2023-12-14 | $252K | — | Filing → |
| MRTX | SELL | 2023-01-19 | $66K | — | Filing → |